Pharmacist Support, a charity centred on bolstering pharmacist well-being, has launched the 'ACTNow' campaign 2023, aimed at promoting and supporting the
health and overall wellbeing of pharmacists. This campaign is launched following the successful 2022 initiative, which heightened awareness about wellbeing in
the pharmacy profession.
Launched in May 2020 in response to COVID-19 challenges, ACTNow has transformed into a dynamic platform fostering positive workplace culture, teamwork, and
individual well-being, Pharmacist Support has said. Its primary goals are to inspire individuals and teams in the profession to prioritise their well-being,
support colleagues, and proactively foster a healthier work environment.
Pharmacist Support emphasised that the 2023 ACTNow campaign will continue to prioritise fostering a positive workplace culture. "This year, the campaign will
provide individuals, pharmacy teams, and employers with essential tools, resources, and strategies to effectively support colleagues dealing with distress,
all while cultivating a growth-oriented mindset within their teams," the charity firm said.
Covid-19 has accelerated a culture change for community pharmacists. Throughout the pandemic, they have been the first line of advice, treatment and referral for common illnesses, and they have Successfully prevented countless unnecessary visits to A&E.
The commitment of the profession to patient care has been widely recognised by both the government and the public. Despite immense pressure, pharmacy teams have risen to the challenges posed by a Global pandemic.
"The extent to which pharmacists went over and above the call of duty, acting outside of their licences from a humanity point of view was extraordinary," said Tess Player, vice president and global head of expert and health influencers at GSK Consumer Healthcare, calling them the "unspoken heroes" of Covid-19.
Pharmacy teams from around the world have shared with her their experiences. Pharmacists in China remained open round the clock and sourced face coverings for
their community and metered out the short supply for their patients.
The Community Pharmacist Consultation Service (CPCS) has been running as a national advanced service since October 2019 to relieve pressure on the National
Health Service which aims to help with on the day demand in relation to minor illness and medicines.
The NHS Community Pharmacist Consultation Service CPCS (NHS CPCS) aims to meet the objectives of the NHS Long Term Plan to use community pharmacists' skills to
advise patients, and to build relationships with GP surgeries, primary care teams and wider NHS providers and to assist with urgent care system repeat prescription
requests. Referrals from the GP referral pathway and urgent care systems and urgent treatment centres are digitally routed to community pharmacies so that patients
can receive same-day appointments and have their queries resolved.
The numbers
Based on the estimated annual number of minor ailment GP appointments, the service was expected to save the NHS up to £640 million per year . Three years later, the
nation has weathered the Covid 19 pandemic, which had widespread effects and put further strain on already overstretched NHS staff.
The pandemic impact has resulted in higher numbers of GP appointments than initially anticipated. Nevertheless, this may offer an opportunity to proactively engage
pharmacy teams in patient contact help ease strain across the wider NHS.
The healthcare landscape has dramatically changed over the years, due to a number of factors, firstly having to navigate Covid-19 and now the advancement of
artificial intelligence (AI) and machine technology, to name a few. As a result, training the next generation of healthcare leaders is more important now than ever.
Let's look at three ways to effectively train the next generation of pharmacists:
Robust Induction Programme
Induction programs are an effective way of training the next generation of pharmacists as they have the ability to provide knowledge, skills and practical
experience to deal with and manage common challenges they're likely to experience in their careers. These programs usually include training in pharmacokinetics,
drug dosages, medication administration, and pharmacotherapy.
Workforce issues, staff retention and capacity continues to be a big concern for the Local Pharmaceutical Committee as it discussed the topics at a recent meeting with the Pharmaceutical Services Negotiating Committee (PSNC).
The meeting, attended by delegates from 66 LPCs, focused on the current challenges faced by community pharmacies as well as the planning for the next year.
Around 64 per cent of delegates said workforce was the top challenge faced by pharmacy contractors, and suggested reducing the migration of pharmacists to Primary Care Networks (PCNs).
Other suggestions included - "improving the development opportunities available for pharmacists and their teams, and rebranding the profession to make community pharmacy a more attractive route for young graduates."
On the development of Integrated Care Systems (ICS), the majority of respondents were positive about their LPC's engagement in the new setting.
Even as the UK agrees deals for 14 million additional vaccine doses from Moderna and Pfizer, the Royal Pharmaceutical Society has renewed its calls for community pharmacies in England to play an increased role in delivering booster jabs for Covid-19.
"Pharmacists and pharmacy teams across the health service in England have been crucial to the success of the flu and Covids-19 vaccination programmes from the outset," said Thorrun Govind, chair of the RPS in England, who has been making a case on national television for an increased role of the profession.
She added: "They continue to go above and beyond to support patient care, engaging with local communities and helping to overcome vaccine hesitancy.
"They've already done so much this year to look after patients in really difficult circumstances, but many will be ready to rise to the challenge of this new national effort."
The National Pharmacy Association (NPA) highlighted the role played by community pharmacies during pandemic to provide urgent care and vital support to people
with long-term medical conditions at its opening remark in the Covid-19 public inquiry held on Tuesday (28 February).
NPA is the core participant in the Covid-19 public inquiry. lawyer Brian Stanton made an opening statement on the NPA's behalf which focused on three areas- health
inequalities and the needs of vulnerable patients; the impact of medicine shortages and medicine price increases and the challenge that community pharmacy faced in
responding to the pandemic and maintaining patient services following long-term under investment.
Stanton said: "The UK's community pharmacies were on the frontline of efforts to limit the impact of coronavirus and to keep people well, and as well as handling a
massive increase in demand for healthcare advice and medicines, they also continued to provide urgent care and vital support to people with long-term medical
conditions.
"However, there are now very many at risk of closure during to underfunding and when the Inquiry comes to consider its recommendations the NPA would encourage
you [the presiding judge] to think about how resilience can be built into future plans."
The statement included a compelling account of the commitment typical of so many pharmacies during the pandemic - from husband and wife Pete and Sukhi Johal, both
NPA members and pharmacists, who co-own Calow Pharmacy in Chesterfield.
Prostate cancer is the most common cancer among men in the United Kingdom, affecting nearly 50,000 men yearly. Combined with the challenges faced across
healthcare during COVID-19, new figures show that prostate cancer accounts for a third of cancers not treated due to the pandemic, with 14,000 'missing patients'
believed to have not undergone treatment since April 2020. It is more urgent than ever that men are encouraged to get checked, as any set-backs in diagnosis can
reduce the pathways available, in turn affecting health outcomes.
Community pharmacy teams play a crucial role in signposting the help available for men who may be concerned about their health. Therefore, it is vital that pharmacy
teams have access to the information they need to correctly direct men to seek prostate cancer guidance. By maximising the trusted relationship between patients and their pharmacists, more can be done to identify the warning signs, helping men to get an earlier diagnosis.
The All-Party Parliamentary Group (APPG) on Pharmacy published a new report on Monday (January 23) that calls for "urgent action" to relieve funding pressure
so there are "opportunities" for community pharmacy teams to deliver even more for their patients.
The report highlights the need for a new "strategic vision" for pharmacy and highlights opportunities for the network to be empowered to deliver even more for
patients.
However, the manifesto also underlines that there are the very real risks that this opportunity may be lost if significant and ongoing pressures are not addressed.
The recommendations are based on written and oral evidence gathered from frontline pharmacists, GPs, professional bodies and healthcare experts.
To harness the potential of pharmacy, the report recommends the Government must take urgent action to relieve the funding pressures on the community pharmacy sector
in the short term and review the long-term funding model for pharmacy.
It also suggested the Government must harness the power of pharmacy to help the NHS deal with the COVID-19 backlog and the UK's growing healthcare challenges.
It further recommended that future commissioning and funding must recognise that community pharmacy is the front door to the NHS for many patients.